Buy Magenta Therapeutics Inc Stock | MGTA Stock Price & Latest News | Public
MGTA

Magenta Therapeutics Inc

$0.00 (0.00%)Today

    About MGTA

    Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers platform that focuses on critical areas of transplant medicine. The company was founded by David Scadden, Der...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.34
    -0.51
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.40

    Actual EPS
    Q4 2020

    Stats

    Market Cap$332,33M
    Volume3,27k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$16.19
    1 Year Low$5.76
    Open$6.56
    High$7.15
    Low$6.53

    Buy any stock with any amount of money.

    Download the App
    Download the app